Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05672953 · ClinicalTrials.gov registry record

Biogeography of the Oral Microbiome

A clinical trial of Oral Microbiome, sponsored by Viome.

Completed
Registry status
20
Enrollment target
1
Study location

NCT05672953 is a study of Oral Microbiome that has completed, run by Viome. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05672953, a study of Oral Microbiome, has completed, sponsored by Viome.

COMPLETED
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.

Conditions Studied

Study Locations (1)

Washington

  • Viome Life Sciences - Bothell

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-05-20
Est. Completion 2021-08-10

Sponsor

Viome

18 total trials

What the Registry Record Tells You About NCT05672953

The ClinicalTrials.gov registry entry for NCT05672953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Oral Microbiome appearing as the primary indexed condition, and to 0 interventions.

NCT05672953 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05672953 about?

NCT05672953 is a clinical study titled "Biogeography of the Oral Microbiome". A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.

What is the current status of trial NCT05672953?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-05-20. Estimated completion is 2021-08-10.

What conditions does trial NCT05672953 study?

This clinical trial studies the following conditions: Oral Microbiome.

Who is sponsoring clinical trial NCT05672953?

This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05672953 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.